/PRNewswire-FirstCall/ -- Cord Blood America, Inc.
(OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it has named Jack Goldberg
, M.D., as Chairman of its Medical Advisory Board.Dr. Goldberg
served as medical director at CorCell
, which is now a Cord Blood America subsidiary, since 1996.He also serves as the Chief of the Division of Hematology and Oncology at Penn Presbyterian Medical Center, University of Pennsylvania Health System.Dr. Goldberg
recently announced for Cord Blood America
the first known worldwide report of a girl with leukemia who was successfully transplanted with her
own umbilical cord blood, which had been stored by CorCell
.It was the first autologous cord blood transplant for childhood leukemia anywhere in the world.He
also appeared on the popular ABC Network's "Good Morning America" to discuss umbilical cord blood banking.
"Since the majority of transplants done worldwide are autologous bone marrow transplants for patients who may benefit from high dose chemotherapy, I believe that in the next 10 years, we will see donors who banked their cord blood benefit by having autologous tissue available to them.If the hematologist and medical oncologist have knowledge that their patient had preserved their cord blood at birth, treatment for that patient may change to allow for a more aggressive high dose therapy to treat the underlying cancers such as Hodgkin's, aggressive lymphoma, sarcoma, and Wilms' tumor," said Dr. Goldberg
...Dr. Goldbergreceived his medical training at the State University of New York (SUNY) Health Science Center in Syracuse, New York.
internship and residency programs at University Hospital
in Boston, Massachusetts, Dr. Goldberg
returned to SUNY
to complete a fellowship program in hematology and medical oncology.He was appointed associate professor of medicine and pathology there and actively conducted research in hematopoiesis and disorders of the blood including leukemia and lymphoma.Dr. Goldbergalso lead the Cooper Cancer Institute and the Division of Hematology and Medical Oncology at Cooper Health System in Camden, N.J., where he was appointed professor of medicine of the institution's affiliated medical school, the Robert WoodJohnson Medical School
.With more than 80 published articles in peer reviewed journals, Dr. Goldberg